{"url_path":"/sec/silo/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-056079-index.html","accession_number":"0001213900-26-056079","cik":"0001514183","ticker":"SILO","issuer_name":"Silo Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-056079-index.html","primary_entity_key":"0001514183","primary_entity_name":"Silo Pharma, Inc."},"word_count":84,"has_tables":true,"body_markdown":"**ITEM 1. LEGAL PROCEEDINGS**\n\n \n\nFrom time to time, we may become involved in various\nlawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an\nadverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such\nlegal proceedings or claims that will have, individually or in the aggregate, a material adverse effect on our business, financial condition\nor operating results."}